Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01559376 |
|
Recruitment Status :
Completed
First Posted : March 21, 2012
Last Update Posted : August 28, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The objectives of the study are two-fold:
- To determine the mean 5 year patency rate of the radial artery graft (Open vs. Endoscopic) of patients who have already had CABG surgery and who previously participated in the centre's RCT back in 2005-2007 using CTA and MPS-MIBI
- To determine patient quality of life at 5 years post CABG surgery
It is hypothesized that the mean 5 year patency rate of the radial artery graft harvested endoscopically will be equal to or have greater patency than the radial artery graft harvested via the conventional/open technique. It is further hypothesized that patient quality of life will be similar amongst patients having had the open vs. endoscopic radial artery graft during CABG surgery.
| Condition or disease |
|---|
| Arteriosclerosis of Arterial Coronary Artery Bypass Graft |
Show detailed description
| Study Type : | Observational |
| Estimated Enrollment : | 118 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography |
| Study Start Date : | February 2012 |
| Actual Primary Completion Date : | February 2014 |
| Actual Study Completion Date : | February 2015 |
| Group/Cohort |
|---|
| Endoscopic radial artery harvest |
| Conventional open radial artery harvest |
- Radial artery graft patency [ Time Frame: Mean 5 years ]Grade A Excellent graft with unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
- Ischemia present in other coronary artery territories [ Time Frame: Mean 5 years ]Areas of decreased perfusion identified by MPS-MIBI scanning in the context of CT - angiographic results
- Identification of left ventricular ejection fraction at rest and stress [ Time Frame: Mean 5 years ]Related in percentage of blood ejected as a fraction of left ventricular end diastolic volume
- Quality of life post CABG via the two questionnaires; the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey. [ Time Frame: Mean 5 years ]Numerical score based on the questionnaire scoring scales
- Stenosis present in other coronary arteries / grafts [ Time Frame: Mean 5 year ]Based on CT - angiographic results. Grade A: unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
-
Patients will be included if they:
- Have previously participated in our RCT from 2005-2007 with an open or endoscopically harvested radial artery graft used as a bypass conduit.
- Willing to give informed consent to participate in the study
Exclusion Criteria:
-
Patients are excluded if they are:
- Expired
- Unable or unwilling to give informed consent
- History of allergic reaction to contrast material used in CTA or severe adverse reactions to medications used in MPS-MIBI procedures
- Kidney dysfunction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01559376
| Canada, Ontario | |
| London Health Sciences Centre, University Hospital | |
| London, Ontario, Canada, N6A 5A5 | |
| London Health Sciences Centre, Victoria Hospital | |
| London, Ontario, Canada, N6A 5W9 | |
| Principal Investigator: | Bob Kiaii, BSc, MD | University of Western Ontario, Lawson Research Institute, University of Western Ontario |
| Responsible Party: | Lawson Health Research Institute |
| ClinicalTrials.gov Identifier: | NCT01559376 |
| Other Study ID Numbers: |
ENDO2012 |
| First Posted: | March 21, 2012 Key Record Dates |
| Last Update Posted: | August 28, 2017 |
| Last Verified: | March 2012 |
|
Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases |

